LifeScan pursues Polymer Technology (US) over test strip patent
This article was originally published in Clinica
Executive Summary
Polymer Technology (US) must stop selling test strips for LifeScan diabetes monitoring systems following a pre-trial judgement. The Federal District Court in Seattle found that Polymer's First Choice strips infringe three LifeScan patents. A jury trial set for February will rule on other patent infringement issues.